| Dr Kamala C Saha, MD | |
|
240 W Thomas Rd, Suite 301, Phoenix, AZ 85013-4407 | |
| (602) 406-7808 | |
| (602) 406-6131 |
| Full Name | Dr Kamala C Saha |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 15 Years |
| Location | 240 W Thomas Rd, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013144666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 47702 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sjhmc Physician Services | 4486646197 | 533 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
LUMEDX Corporation, a leading provider of vendor-neutral cardiovascular imaging and information systems, announced today that it has contracted to provide Phoebe Putney Memorial Hospital with a comprehensive CVIS that will integrate patient data and images across five different sites. The LUMEDX CVIS will consolidate data, improve physician access to patient information, streamline clinical workflows, and support outcomes analysis and registry reporting for the Phoebe Heart and Vascular Center.
Montana State University scientists in the Department of Chemistry and Bio-chemistry published new research this week that could one day affect the lives of millions around the world who suffer from blood iron disorders.
New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
› Verified 8 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
LUMEDX Corporation, a leading provider of vendor-neutral cardiovascular imaging and information systems, announced today that it has contracted to provide Phoebe Putney Memorial Hospital with a comprehensive CVIS that will integrate patient data and images across five different sites. The LUMEDX CVIS will consolidate data, improve physician access to patient information, streamline clinical workflows, and support outcomes analysis and registry reporting for the Phoebe Heart and Vascular Center.
Montana State University scientists in the Department of Chemistry and Bio-chemistry published new research this week that could one day affect the lives of millions around the world who suffer from blood iron disorders.
New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamala C Saha, MD 240 W Thomas Rd, Suite 301, Phoenix, AZ 85013-4407 Ph: (602) 406-7808 | Dr Kamala C Saha, MD 240 W Thomas Rd, Suite 301, Phoenix, AZ 85013-4407 Ph: (602) 406-7808 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
LUMEDX Corporation, a leading provider of vendor-neutral cardiovascular imaging and information systems, announced today that it has contracted to provide Phoebe Putney Memorial Hospital with a comprehensive CVIS that will integrate patient data and images across five different sites. The LUMEDX CVIS will consolidate data, improve physician access to patient information, streamline clinical workflows, and support outcomes analysis and registry reporting for the Phoebe Heart and Vascular Center.
Montana State University scientists in the Department of Chemistry and Bio-chemistry published new research this week that could one day affect the lives of millions around the world who suffer from blood iron disorders.
New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
› Verified 8 days ago
Dr. George David Goldberg, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2145 E Kaler Dr, Phoenix, AZ 85020 Phone: 602-943-2400 | |
Andrea Oliver Skelton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 16620 N 40th St Ste H4, Phoenix, AZ 85032 Phone: 602-464-9576 Fax: 602-626-8901 | |
Mr. Joseph Andrew Vitagliano, PA-C Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1110 E Missouri Ave Ste 110, Phoenix, AZ 85014 Phone: 480-542-8202 | |
Robin Laurie Mcfarlane, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2266 | |
Kevin Yang, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5011 | |
Dr. Michael A Stein, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 240 W Thomas Rd # 404, Phoenix, AZ 85013 Phone: 602-406-6262 | |
Dr. Lee Ann Kelley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4602 N 16th St Ste 100, Phoenix, AZ 85016 Phone: 602-795-1834 Fax: 602-795-2608 |